VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most intractable malignancies to overcome clinically due to its insidious onset as well as rapid progression. It is urgent to seek new diagnostic markers and therapeutic targets in order to furthest ameliorate the prognosis of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jichuan, Quan, Gang, Huang, Wei, Jiang, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463957/
https://www.ncbi.nlm.nih.gov/pubmed/37626304
http://dx.doi.org/10.1186/s12964-023-01209-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463957/
https://www.ncbi.nlm.nih.gov/pubmed/37626304
http://dx.doi.org/10.1186/s12964-023-01209-x

Ejemplares similares